Spruce BioSciences

IPO

Novel Therapies for Rare Endocrine Disorders

South San Francisco, United States · Founded 2016 · $138.0M raised

Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$138.0M
Last Round
$50.0M Venture RoundFeb 2020
Rounds
3

About

Spruce BioSciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine and neurological disorders. Headquartered in South San Francisco, California, the company targets underserved patient populations with significant unmet medical needs.

Summary

Spruce BioSciences is a Biotech company based in South San Francisco, United States, founded in 2016. It has raised $138.0M in total across 3 rounds, most recently a $50.0M Venture Round round in Feb 2020. Investors include Omega Funds, Abingworth Bioventures and Novo Holdings A/S.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPOOct 2020
$90.0M

Sign up to see all 4 rounds

Venture Round through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Spruce BioSciences on Indexed.vc
<a href="https://indexed.vc/companies/spruce-biosciences"><img src="https://indexed.vc/api/badge/company/spruce-biosciences" alt="Spruce BioSciences on Indexed.vc" width="260" height="76" /></a>